These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1890 related articles for article (PubMed ID: 32967006)

  • 1. SARS-CoV-2 vaccines in development.
    Krammer F
    Nature; 2020 Oct; 586(7830):516-527. PubMed ID: 32967006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The underdog coronavirus vaccines that the world will need if front runners stumble.
    Callaway E
    Nature; 2020 Sep; 585(7825):332-333. PubMed ID: 32908297
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronavirus vaccines get a biotech boost.
    Dance A
    Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
    [No Abstract]   [Full Text] [Related]  

  • 5. The COVID-19 vaccine development landscape.
    Thanh Le T; Andreadakis Z; Kumar A; Gómez Román R; Tollefsen S; Saville M; Mayhew S
    Nat Rev Drug Discov; 2020 May; 19(5):305-306. PubMed ID: 32273591
    [No Abstract]   [Full Text] [Related]  

  • 6. Understanding COVID-19 vaccine efficacy.
    Lipsitch M; Dean NE
    Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
    [No Abstract]   [Full Text] [Related]  

  • 7. What China's speedy COVID vaccine deployment means for the pandemic.
    Cyranoski D
    Nature; 2020 Oct; 586(7829):343-344. PubMed ID: 33033397
    [No Abstract]   [Full Text] [Related]  

  • 8. A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool.
    Todorov G; Uversky VN
    Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33066343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. China's coronavirus vaccines are leaping ahead - but face challenges as virus wanes.
    Cyranoski D
    Nature; 2020 Aug; 584(7819):17-18. PubMed ID: 32737453
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospects for a safe COVID-19 vaccine.
    Haynes BF; Corey L; Fernandes P; Gilbert PB; Hotez PJ; Rao S; Santos MR; Schuitemaker H; Watson M; Arvin A
    Sci Transl Med; 2020 Nov; 12(568):. PubMed ID: 33077678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
    Boudjelal M; Nehdi A; Islam I
    Expert Opin Drug Discov; 2020 Nov; 15(11):1233-1235. PubMed ID: 32543297
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitor for COVID-19 vaccine resistance evolution during clinical trials.
    Kennedy DA; Read AF
    PLoS Biol; 2020 Nov; 18(11):e3001000. PubMed ID: 33166303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 14. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronavirus vaccines leap through safety trials - but which will work is anybody's guess.
    Callaway E
    Nature; 2020 Jul; 583(7818):669-670. PubMed ID: 32710003
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
    JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.
    Slaoui M; Hepburn M
    N Engl J Med; 2020 Oct; 383(18):1701-1703. PubMed ID: 32846056
    [No Abstract]   [Full Text] [Related]  

  • 18. If a coronavirus vaccine arrives, can the world make enough?
    Khamsi R
    Nature; 2020 Apr; 580(7805):578-580. PubMed ID: 32273621
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of vaccines for SARS-CoV-2.
    Ng WH; Liu X; Mahalingam S
    F1000Res; 2020; 9():. PubMed ID: 32850116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
    Moise L; Ross TM; Hoft DF; Martin WD; De Groot AS
    Expert Rev Vaccines; 2020 Sep; 19(9):781-784. PubMed ID: 32962468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 95.